MDxHealth SA
MDXH
$3.55
$0.082.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 36.18% | -11.39% | -8.49% | 27.31% | 13.81% |
| Total Depreciation and Amortization | 16.22% | 15.17% | 1.24% | 16.14% | -52.84% |
| Total Amortization of Deferred Charges | 119.53% | -- | -- | -- | 158.04% |
| Total Other Non-Cash Items | -31.40% | -1.35% | 67.89% | -47.69% | 47.31% |
| Change in Net Operating Assets | 42.06% | -32.08% | 63.54% | -153.15% | -17.44% |
| Cash from Operations | 57.72% | -31.84% | 23.51% | -29.22% | 24.16% |
| Capital Expenditure | 44.83% | 14.63% | 58.57% | 72.05% | 73.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 257.93% | 202.07% | -0.96% | 11.75% | 58.16% |
| Cash from Investing | 66.12% | 97.04% | 50.70% | 50.08% | 68.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 92.67% | -8.24% | -7,444.66% | -25.49% | -192.68% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -122.57% | -83.63% | -111.50% | -34.42% | -46.13% |
| Cash from Financing | 138.55% | 1,581.41% | 934.17% | -104.58% | -1,481.38% |
| Foreign Exchange rate Adjustments | -222.22% | -97.12% | 95.72% | 80.00% | -92.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.06% | 513.26% | 178.00% | -124.08% | 12.90% |